Authors: FRANZBLAU SG CHAN GP GARCIAIGNACIO BG CHAVEZ VE LIVELO JB JIMENEZ CL PARRILLA MLR CALVO RF WILLIAMS DL GILLIS TP

Citation: Sg. Franzblau et al., CLINICAL-TRIAL OF FUSIDIC ACID FOR LEPROMATOUS LEPROSY, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1651-1654

Authors: CHAN GP GARCIAIGNACIO BY CHAVEZ VE LIVELO JB JIMENEZ CL PARRILLA MLR FRANZBLAU SG

Citation: Gp. Chan et al., CLINICAL-TRIAL OF CLARITHROMYCIN FOR LEPROMATOUS LEPROSY, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 515-517

Authors: CHAN GP GARCIAIGNACIO BY CHAVEZ VE LIVELO JB JIMENEZ CL PARRILLA MLR FRANZBLAU SG

Citation: Gp. Chan et al., CLINICAL-TRIAL OF SPARFLOXACIN FOR LEPROMATOUS LEPROSY, Antimicrobial agents and chemotherapy, 38(1), 1994, pp. 61-65

Authors: FRANZBLAU SG PARRILLA MLR CHAN GP

Citation: Sg. Franzblau et al., SPARFLOXACIN IS MORE BACTERICIDAL THAN OFLOXACIN AGAINST MYCOBACTERIUM-LEPRAE IN MICE, International journal of leprosy and other mycobacterial diseases, 61(1), 1993, pp. 66-69

Authors: CHO SN KIM SH CELLONA RV CHAN GP FAJARDO TT WALSH GP KIM JD

Citation: Sn. Cho et al., PREVALENCE OF IGM ANTIBODIES TO PHENOLIC GLYCOLIPID-I AMONG HOUSEHOLDCONTACTS AND CONTROLS IN KOREA AND THE PHILIPPINES, Leprosy review, 63(1), 1992, pp. 12-20